Product Information
HYOSCYAMINE 0.125 MG ODT is a generic product labeled by Acella Pharmaceuticals, LLC, priced at $0.1442 per EA under NDC 42192033801. Its NADAC has been published 408 times since Dec 12, 2018.
Strength
.125 mg/1
Manufacturer
Acella Pharmaceuticals, LLCNDC
42192033801
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYOSCYAMINE SULFATEApproval Type
Unapproved
On Market Since
5/19/2011
Price Statistics
The NADAC for HYOSCYAMINE 0.125 MG ODT has been published 408 times since Dec 12, 2018, and over the history we have for it it has declined 36.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1442 per EA |
|---|---|
| All-time high | $0.2326 (Oct 14, 2020) |
| All-time low | $0.1106 (Sep 21, 2022) |
| 52-week high | $0.2280 |
| 52-week low | $0.1442 |
| Median price | $0.1878 |
| Average price | $0.1844 |
| Largest weekly change | +52.9% (Oct 19, 2022) |
| Weeks tracked | 408 |
| Tracking since | Dec 12, 2018 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Acella Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
hyoscyamine sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYOSCYAMINE 0.125 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for HYOSCYAMINE 0.125 MG ODT, manufactured by Acella Pharmaceuticals, LLC, is $0.1442 per EA (NDC 42192033801), effective Sep 30, 2026.
How has the price of HYOSCYAMINE 0.125 MG ODT changed over time?
Over the history we have for it, the NADAC for HYOSCYAMINE 0.125 MG ODT has declined 36.0%. It has been tracked across 408 weekly CMS publications since Dec 12, 2018.
What are the highest and lowest recorded NADAC prices for HYOSCYAMINE 0.125 MG ODT?
Since Dec 12, 2018, the NADAC for HYOSCYAMINE 0.125 MG ODT has ranged from a low of $0.1106 (Sep 21, 2022) to a high of $0.2326 (Oct 14, 2020), with a median of $0.1878 per EA.
Are there cheaper alternatives to HYOSCYAMINE 0.125 MG ODT?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as HYOSCYAMINE 0.125 MG ODT in a comparable dosage form, but none are currently priced below it.
Who manufactures HYOSCYAMINE 0.125 MG ODT?
HYOSCYAMINE 0.125 MG ODT (NDC 42192033801) is labeled by Acella Pharmaceuticals, LLC, and CMS classifies it as a generic product.